David Newman
Senior Product Director, Tykerb, GlaxoSmithKline
NOTED FOR: Launch of oncology treatment Tykerb
EXCEEDED RESULTS: Treated 5,500 patients
On what motivates him to succeed:
David Newman
|
We think we have it tough. But that's nothing compared to fighting breast cancer. These women help us put our work in perspective,
and give us a sense of mission to not necessarily sell Tykerb, but instead make sure every patient gets its benefit of efficacy.
In a therapeutic area like oncology, you have a chance to make a real difference. That focus is what keeps me motivated day
in and day out.
PharmExec Blog
Follow Us
RSS
Bookstore
